Vassar, Robert

Zylem Biosciences Inc, based in Chicago, IL, is dedicated to extending healthy human lifespan through the development of therapeutics targeting cancer, ocular, and cardiovascular diseases, along with anti-aging treatments focused on mitochondrial restoration. The company's innovative approach relies on its proprietary metabolic redox modulators (MRMs), which serve as tunable mimics of natural molecules that effectively modulate oxidative stress and inflammation—key contributors to disease and aging. The firm's pipeline is primarily concentrated on targeted oncology, where MRMs aim to induce a "Metabolic Checkmate" by addressing three hallmarks of cancer simultaneously: enhancing immune destruction, reducing tumor-promoting inflammation, and promoting cancer cell death through increased oxidative stress. This pioneering work positions Zylem as a significant player in the biotechnology field, tackling previously undruggable targets to offer new avenues for treatment. Generated from the website

The American Dental Association (ADA) is a leading organization dedicated to advancing the dental profession and promoting oral health through education, advocacy, and research. With a focus on evidence-based practices, the ADA provides resources and support for dental professionals to enhance their careers and improve patient care. In addition to offering continuing education courses and credentialing services, the ADA actively engages in legislative advocacy to protect the interests of dentists and their patients. The organization also evaluates oral health products for safety and effectiveness through its ADA Seal of Acceptance program, ensuring that consumers have access to reliable dental care solutions. Generated from the website